Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

被引:7
|
作者
Balmuri, Nayimisha [1 ,2 ]
Soulsby, William Daniel [3 ]
Cooley, Victoria [2 ]
Gerber, Linda [2 ]
Lawson, Erica [3 ]
Goodman, Susan [1 ,2 ]
Onel, Karen [1 ,2 ]
Mehta, Bella [1 ,2 ]
机构
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY 10065 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
HEALTH DISPARITIES; RADIOGRAPHIC PROGRESSION; SOCIOECONOMIC MEASURES; DISEASE OUTCOMES; CHILDREN; CARE; ACCESS; DELAY;
D O I
10.1186/s12969-021-00610-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrier to early treatment of pJIAs is delayed presentation to a pediatric rheumatologist. We examined the impact of community poverty level, a key social determinant of health, on time from patient reported symptom onset to first pediatric rheumatology visit among pJIA patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods: This is a cohort study of pJIA patients in the CARRA registry who lived in the United States from July 2015-February 2020. The primary exposure was community poverty level derived by geocoding patient addresses. The primary outcome was time to first rheumatology appointment. Kaplan-Meier analysis was performed to analyze time to first rheumatologist visit, stratified by community poverty and family income. Log-rank tests were used to identify differences between groups. Adjusted cox proportional-hazards models were used to determine the relationship between community poverty level and time from onset of disease symptoms to date first seen by rheumatologist. Results: A total of 1684 patients with pJIA meeting study inclusion and exclusion criteria were identified. Median age of onset of pJIA was 7 years (IQR 3, 11), 79% were female, 17.6% identified as minority race and/or ethnicity, and 19% were from communities with >= 20% community poverty level. Kaplan-Meier analysis by community poverty level (< 20% vs >= 20%) yielded no significant differences with time to initial presentation to a pediatric rheumatologist (p = 0.6). The Cox proportional hazards model showed that patients with >= 20% community poverty level were 19% less likely (adjusted HR 0.81, 95% CI 0.67-0.99, p = 0.038) to be seen by a rheumatologist compared to patients with < 20% community poverty level, at the same time point, after adjusting for sex, race/ethnicity, insurance, education level, morning stiffness, RF status, and baseline CHAQ. Conclusion: In this study of pJIA patients in the CARRA registry, increased community poverty level is associated with longer time to presentation to a pediatric rheumatologist after symptom onset.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Pediatric and Adolescent Rheumatology -A rapidly developing Field in Pediatrics Current Status of juvenile idiopathic Arthritis and juvenile Dermatomyositis
    Huppertz, H. -I.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (07): : 585 - 586
  • [22] SAFETY OF ADALIMUMAB IN PEDIATRIC PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, ENTHESITIS-RELATED ARTHRITIS, PSORIASIS, AND CROHN'S DISEASE
    Horneff, G.
    Seyger, M. M. B.
    Arikan, D.
    Kalabic, J.
    Anderson, J. K.
    Lazar, A.
    Williams, D. A.
    Wang, C.
    Tarzynski-Potempa, R.
    Hyams, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 265 - 265
  • [23] Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
    Martini, Alberto
    Ravelli, Angelo
    Avcin, Tadej
    Beresford, Michael W.
    Burgos-Vargas, Ruben
    Cuttica, Ruben
    Ilowite, Norman T.
    Khubchandani, Raju
    Laxer, Ronald M.
    Lovell, Daniel J.
    Petty, Ross E.
    Wallace, Carol A.
    Wulffraat, Nico M.
    Pistorio, Angela
    Ruperto, Nicolino
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (02) : 190 - 197
  • [24] Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease
    Horneff, Gerd
    Seyger, Marieke M. B.
    Arikan, Dilek
    Kalabic, Jasmina
    Anderson, Jaclyn K.
    Lazar, Andreas
    Williams, David A.
    Wang, Chen
    Tarzynski-Potempa, Rita
    Hyams, Jeffrey S.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [25] Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
    Lovell, Daniel
    Ruperto, Nicolino
    Kingsbury, Daniel J.
    Burgos-Vargas, Ruben
    Imagawa, Tomoyuki
    Horneff, G.
    Quartier, Pierre
    Goodman, Steven
    Reiff, Andreas
    Giannini, Edward H.
    Cardoso, Anabela
    Anderson, Jaclyn K.
    Varothai, Nupun A.
    Kalabic, Jasmina
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease
    Horneff, Gerd
    Seyger, Marieke M. B.
    Arikan, Dilek
    Kalabic, Jasmina
    Anderson, Jaclyn K.
    Lazar, Andreas
    Williams, David A.
    Wang, Chen
    Tarzynski-Potempa, Rita
    Hyams, Jeffrey S.
    JOURNAL OF PEDIATRICS, 2018, 201 : 166 - +
  • [27] Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
    Junko Yasumura
    Masato Yashiro
    Nami Okamoto
    Kosuke Shabana
    Hiroaki Umebayashi
    Naomi Iwata
    Yuka Okura
    Tomohiro Kubota
    Masaki Shimizu
    Minako Tomiita
    Yasuo Nakagishi
    Kenichi Nishimura
    Ryoki Hara
    Mao Mizuta
    Takahiro Yasumi
    Fumiya Yamaide
    Hiroyuki Wakiguchi
    Masao Kobayashi
    Masaaki Mori
    Pediatric Rheumatology, 17
  • [28] Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
    Yasumura, Junko
    Yashiro, Masato
    Okamoto, Nami
    Shabana, Kosuke
    Umebayashi, Hiroaki
    Iwata, Naomi
    Okura, Yuka
    Kubota, Tomohiro
    Shimizu, Masaki
    Tomiita, Minako
    Nakagishi, Yasuo
    Nishimura, Kenichi
    Hara, Ryoki
    Mizuta, Mao
    Yasumi, Takahiro
    Yamaide, Fumiya
    Wakiguchi, Hiroyuki
    Kobayashi, Masao
    Mori, Masaaki
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [29] Safety of adalimumab in pediatric patients with psoriasis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, and Crohn's disease
    Seyger, M.
    Horneff, G.
    Arikan, D.
    Kalabic, J.
    Anderson, J.
    Lazar, A.
    Williams, D.
    Wang, C.
    Tarzynski-Potempa, R.
    Hyams, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 27 - 27
  • [30] Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's Disease
    Horneff, Gerd
    Seyger, Marieke M. B.
    Arikan, Dilek
    Kalabic, Jasmina
    Anderson, Jaclyn K.
    Lazar, Andreas
    Williams, David A.
    Wang, Chen
    Tarzynski-Potempa, Rita
    Hyams, Jeffrey S.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 66 - 69